EURODEP Company Profile

Background

Company Overview

Founded in August 2001, EURODEP is a pharmaceutical depository specializing in the storage and distribution of a wide range of health-related products, including human and veterinary medicines, medical devices, cosmetics, health and wellness products, dietary supplements, and nutritional items. As a wholly-owned subsidiary of the Astera Group since 2015, EURODEP has established itself as a key player in the pharmaceutical logistics sector, offering comprehensive services that encompass storage, distribution, customer relationship management, billing, and e-commerce solutions.

Mission and Vision

EURODEP is committed to transforming logistics into a competitive advantage for its clients by delivering high-quality, efficient, and reliable services. The company's vision is to be a leader in pharmaceutical logistics, ensuring the seamless delivery of health products to various stakeholders, including pharmacies, hospitals, and specialized stores.

Key Strategic Focus

Core Objectives

Comprehensive Service Offering: Providing end-to-end logistics solutions, from storage to distribution, tailored to the specific needs of the pharmaceutical industry.

Regulatory Compliance: Maintaining all necessary authorizations and adhering to Good Distribution Practices to ensure the highest standards in pharmaceutical logistics.

Areas of Specialization

Product Range: Handling a diverse portfolio that includes human and veterinary medicines, medical devices, cosmetics, health and wellness products, dietary supplements, and nutritional items.

Clientele: Serving a broad spectrum of clients such as pharmacies, parapharmacies, wholesalers, healthcare institutions, specialized stores, and health professionals.

Key Technologies Utilized

EURODEP employs advanced logistics technologies to manage its operations efficiently, including automated storage systems and sophisticated inventory management software.

Primary Markets Targeted

The company operates extensively across metropolitan France and engages in export activities to overseas territories and international markets.

Financials and Funding

Financial Performance

As of December 31, 2024, EURODEP reported a turnover of €354 million, reflecting a 3.7% decrease from the previous year. The net loss for the same period was €2.6 million, an improvement of 20.86% compared to the prior year. The company's total assets stood at €86.5 million, with a solvency ratio of -4.4%.

Funding History

EURODEP operates as a subsidiary of the Astera Group, which provides financial backing and strategic support. Specific details regarding external funding rounds or investments are not publicly disclosed.

Pipeline Development

EURODEP's primary focus is on logistics and distribution services rather than product development. Therefore, it does not have a pipeline of products in development.

Technological Platform and Innovation

Proprietary Technologies

The company utilizes proprietary logistics systems designed to optimize storage and distribution processes, ensuring timely and accurate delivery of products.

Significant Scientific Methods

While EURODEP does not engage in scientific research, it employs advanced methodologies in logistics management, including automated storage solutions and real-time inventory tracking.

Leadership Team

EURODEP MANAGEMENT: Serving as the President, overseeing the company's strategic direction and operations.

Christophe Sceau: General Manager, responsible for the day-to-day management and implementation of company policies.

Leadership Changes

There have been no recent significant changes or appointments within EURODEP's leadership team.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical logistics market is characterized by stringent regulatory requirements and the need for high precision in storage and distribution. The market is competitive, with several players offering specialized services to meet the demands of the healthcare sector.

Competitor Analysis

EURODEP's competitors include companies like Macrofarm, Farmacia Igea, and Farmacie Lombardi, which provide similar logistics and distribution services for pharmaceutical products.

Strategic Collaborations and Partnerships

EURODEP collaborates closely with its parent company, the Astera Group, to leverage synergies in logistics and distribution. Additionally, the company partners with various pharmaceutical laboratories and healthcare providers to ensure the efficient delivery of products.

Operational Insights

Strategic Considerations

EURODEP's strategic positioning is strengthened by its comprehensive service offerings and adherence to regulatory standards. The company's proximity to major transportation hubs, such as Roissy-Charles de Gaulle Airport, enhances its distribution capabilities.

Competitive Advantages

Comprehensive Service Offering: Providing end-to-end logistics solutions tailored to the pharmaceutical industry.

Regulatory Compliance: Maintaining all necessary authorizations and adhering to Good Distribution Practices.

Strategic Location: Operating from sites near major transportation hubs to facilitate efficient distribution.

Strategic Opportunities and Future Directions

EURODEP aims to expand its market presence by enhancing its service offerings and exploring new partnerships within the healthcare sector. The company is also focused on integrating advanced technologies to further optimize its logistics operations.